Cargando…

Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population

SARS-CoV-2 RT-PCR, the gold standard for diagnostic testing, may not be readily available or logistically applicable for routine COVID-19 testing in many rural communities in the United States. In this validation study, we compared the BinaxNOW™ COVID-19 Test Ag Card with SARS-CoV-2 RT-PCR in 214 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pollreis, Rachel E., Roscoe, Clay, Phinney, Rachel J., Malesha, Surabhi S., Burns, Matthew C., Ceniseros, Aimee, Washington, Charles H., Nutting, Andrew J., Ball, Christopher L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638850/ https://www.ncbi.nlm.nih.gov/pubmed/34855887 http://dx.doi.org/10.1371/journal.pone.0260862

Ejemplares similares

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

Accuracy of Expired BinaxNOW Rapid Antigen Tests
por: Vaeth, Mary Jane E., et al.
Publicado: (2023)

Diagnostic value of BinaxNOW antigen card for Severe Acute Respiratory Syndrome Coronavirus 2
por: Mai, Yue-Xue, et al.
Publicado: (2023)

Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern
por: Rao, Anuradha, et al.
Publicado: (2022)

The BinaxNOW pneumococcal antigen test: An adjunct for diagnosis of pneumococcal bacteraemia
por: Tootla, Hafsah D., et al.
Publicado: (2021)

Comparison of Sofia Legionella FIA and BinaxNOW® Legionella urinary antigen card in two national reference centers
por: Beraud, L., et al.
Publicado: (2015)

Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting
por: Okoye, Nkemakonam C., et al.
Publicado: (2021)

Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration
por: Frediani, Jennifer K., et al.
Publicado: (2021)

Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting
por: Sood, Neeraj, et al.
Publicado: (2021)

Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA
por: Surasi, Krishna, et al.
Publicado: (2021)

Comparison of a Prototype SARS-CoV-2 Lateral Flow IMMUNOASSAY with the BinaxNOW(TM) COVID-19 Antigen CARD
por: Hill, Haydon J., et al.
Publicado: (2022)

Comparison of the ImmuView and the BinaxNOW antigen tests in detection of Streptococcus pneumoniae and Legionella pneumophila in urine
por: Athlin, S., et al.
Publicado: (2017)

366. Abbott BinaxNOW Rapid Antigen Test Performance in Detecting SARS-CoV-2 Infections in a COVID-19 Outbreak Among Horse Racetrack Workers
por: Surasi, Krishna, et al.
Publicado: (2021)

Performance of BinaxNOW G6PD Deficiency Point-of-Care Diagnostic in P. vivax-Infected Subjects
por: Osorio, Lyda, et al.
Publicado: (2015)

Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening
por: Stokes, Nadarra L., et al.
Publicado: (2021)

Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020
por: Prince-Guerra, Jessica L., et al.
Publicado: (2021)

Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020
por: Almendares, Olivia, et al.
Publicado: (2022)

High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site during Prevalent Delta Variant Period
por: Sun, Kristie J., et al.
Publicado: (2022)

Comparison of BinaxNOW and SARS-CoV-2 qRT-PCR Detection of the Omicron Variant from Matched Anterior Nares Swabs
por: Landaverde, Lena, et al.
Publicado: (2022)

Implementation and Accuracy of BinaxNOW Rapid Antigen COVID-19 Test in Asymptomatic and Symptomatic Populations in a High-Volume Self-Referred Testing Site
por: Siddiqui, Zishan K., et al.
Publicado: (2021)

SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 antigen self tests
por: Nguyen, Phuong-Vi, et al.
Publicado: (2023)

Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges
por: Schrom, John, et al.
Publicado: (2023)

Diagnostic utility of BINAX NOW RSV – an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence
por: Jonathan, Nteimam
Publicado: (2006)

Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires’ disease or pneumococcal pneumonia and meningitis
por: Edelstein, Paul H., et al.
Publicado: (2020)

Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
por: Pilarowski, Genay, et al.
Publicado: (2020)

Further evidence of the cross-reactivity of the Binax NOW® Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi
por: Wanji, Samuel, et al.
Publicado: (2016)

Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
por: James, Allison E., et al.
Publicado: (2021)

Real-time PCR compared to Binax NOW and cytospin-immunofluorescence for detection of influenza in hospitalized patients
por: Landry, Marie L., et al.
Publicado: (2008)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)

Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients
por: Harrington, Amanda, et al.
Publicado: (2020)

Comparative evaluation of two rapid field tests for malaria diagnosis: Partec Rapid Malaria Test(® )and Binax Now(® )Malaria Rapid Diagnostic Test
por: Nkrumah, Bernard, et al.
Publicado: (2011)

Compendio Abbott.
Publicado: (1953)

Abbott’s at the Top
Publicado: (1909)

Abbott’s Scissors
Publicado: (1883)

Abbott’s Scissors
Publicado: (1884)

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022)

Comparison of Binax NOW urine antigen test and pneumococcal DNA assay using qPCR before and after nasopharyngeal swabbing in healthy Malawian children
por: Lees, E.A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jphnfjlm6odcoc42fisea6vrdc